Repros Updates Androxal(R) Global Regulatory Status

World News: . []

THE WOODLANDS Texas Dec 29 2014 GLOBE NEWSWIRE -- Repros Therapeutics IncNasdaqRPRX today updated the regulatory status for its drug Androxal. Androxal is an oral therapy for the treatment of low testosterone due to secondary hypogonadism . Repr...

More news and information about Repros Therapeutics Inc.

Published By:

Globe Newswire: 21:15 GMT Monday 29th December 2014

Published: .

Search for other references to "repros" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us